These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 15127591

  • 1. [Peroxisome proliferator-activated receptors and atherosclerosis].
    Jin N, Wang X.
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):13-8. PubMed ID: 15127591
    [Abstract] [Full Text] [Related]

  • 2. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V, Chinetti G, Fruchart JC, Staels B.
    J Soc Biol; 2002 Jan; 196(1):47-52. PubMed ID: 12134632
    [Abstract] [Full Text] [Related]

  • 3. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease.
    Keller JM, Collet P, Bianchi A, Huin C, Bouillaud-Kremarik P, Becuwe P, Schohn H, Domenjoud L, Dauça M.
    Int J Dev Biol; 2000 Aug; 44(5):429-42. PubMed ID: 11032176
    [Abstract] [Full Text] [Related]

  • 4. [Lipid metabolism related nuclear receptor--the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR)].
    Kawada T.
    Nihon Rinsho; 1998 Jul; 56(7):1722-8. PubMed ID: 9702044
    [Abstract] [Full Text] [Related]

  • 5. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
    Andrééva-Gatéva P.
    Ann Biol Clin (Paris); 2003 Jul; 61(3):295-303. PubMed ID: 12805006
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N, Duez H, Fruchart JC, Staels B.
    Circ Res; 2004 May 14; 94(9):1168-78. PubMed ID: 15142970
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptors as molecular targets for drug therapy.
    Sridhar GR.
    J Assoc Physicians India; 2003 Jan 14; 51():49-52. PubMed ID: 12693455
    [Abstract] [Full Text] [Related]

  • 8. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA.
    Arterioscler Thromb Vasc Biol; 2006 Jan 14; 26(1):28-40. PubMed ID: 16239592
    [Abstract] [Full Text] [Related]

  • 9. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J, Wójcicka G, Jamroz A.
    Postepy Hig Med Dosw; 2003 Jan 14; 57(2):199-217. PubMed ID: 12866356
    [Abstract] [Full Text] [Related]

  • 10. PPAR alpha, fibrates, lipid metabolism and inflammation.
    Duval C, Fruchart JC, Staels B.
    Arch Mal Coeur Vaiss; 2004 Jun 14; 97(6):665-72. PubMed ID: 15283041
    [Abstract] [Full Text] [Related]

  • 11. Roles of PPARs in health and disease.
    Kersten S, Desvergne B, Wahli W.
    Nature; 2000 May 25; 405(6785):421-4. PubMed ID: 10839530
    [Abstract] [Full Text] [Related]

  • 12. The mechanisms of action of PPARs.
    Berger J, Moller DE.
    Annu Rev Med; 2002 May 25; 53():409-35. PubMed ID: 11818483
    [Abstract] [Full Text] [Related]

  • 13. [New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis].
    Fruchart JC, Staels B, Duriez P.
    Bull Acad Natl Med; 2001 May 25; 185(1):63-74; discussion 74-5. PubMed ID: 11474570
    [Abstract] [Full Text] [Related]

  • 14. The role of PPAR alpha in obesity.
    Seedorf U, Assmann G.
    Nutr Metab Cardiovasc Dis; 2001 Jun 25; 11(3):189-94. PubMed ID: 11590995
    [Abstract] [Full Text] [Related]

  • 15. PPARs and the complex journey to obesity.
    Evans RM, Barish GD, Wang YX.
    Nat Med; 2004 Apr 25; 10(4):355-61. PubMed ID: 15057233
    [Abstract] [Full Text] [Related]

  • 16. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B, Dembińska-Kieć A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K.
    J Physiol Pharmacol; 2005 Jun 25; 56(2):149-62. PubMed ID: 15985699
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun 25; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 18. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S.
    Neuroscience; 2005 Jun 25; 130(2):325-37. PubMed ID: 15664689
    [Abstract] [Full Text] [Related]

  • 19. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P.
    Circulation; 2004 Nov 16; 110(20):3259-69. PubMed ID: 15533870
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptors (PPARs) in health and disease.
    Ehrmann J, Vavrusová N, Collan Y, Kolár Z.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2002 Dec 16; 146(2):11-4. PubMed ID: 12572888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.